Back to Authors

Davis, Mark D.P.

0000-0003-0936-580X

Mayo Clinic

Mayo Clinic

Citations 91

Management of erythromelalgia: a narrative review and expert opinion
Aldhalaan, Jumana , Sartori-Valinotti, Julio C., Davis, Mark D.P. , Sandroni, Paula , Davis, Mark Denis P., Sartori‐Valinotti, Julio C. , Sandroni, Paola

Expert Opinion on Pharmacotherapy | September 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-12

10.1080/14656566.2026.2734121 Get It

Acrylate Patch Testing for Allergic Contact Dermatitis Over 28 Years: Hierarchical Clustering for Subgroup Analysis and Computational Optimization for Patch Test Selection
Colquitt, JennaKay , Yiannias, James A. , Davis, Mark D.P., Hall, Matthew R., Youssef, Molly J. , Yang, Yul W. , Colquitt, JennaKay , Davis, Mark D.P.

Dermatitis® | August 22, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/17103568261479501 Get It

Background: Acrylate allergy is rising, with many patients showing patch test positivity to multiple acrylates. Understanding acrylate sensitivity can guide avoidance and optimize screening. Objectives: To quantify acrylate patch test positivity, define subgroups using hierarchical clustering, and algorithmically optimize acrylate patch testing series. Methods: We conducted a retrospective review of 27 acrylate allergens patch tested at 3 Mayo Clinic sites (Arizona, Florida, Minnesota) from 1997 to 2024; 14 had ≥1% positivity. Pairwise copositivity rates were background-corrected and analyzed using hierarchical clustering, followed by computational optimization for patch test screening. Results: Among 17,148 patients, 90,818 tests yielded 1,557 positives (1.71%). Most frequent positive reactions were 2-hydroxyethyl acrylate 0.1% (HEA, 5.4%), 2-hydroxypropyl methacrylate 2% (HPMA, 5.0%), and 2-hydroxyethyl methacrylate 2% (HEMA, 4.6%). Clustering revealed 2 general subgroups, with ethyl cyanoacrylate 10% (ECA) showing minimal copositivity to other acrylates. Optimization analysis for screening showed that one allergen (HEMA) captured 49.4% of sensitized patients; 2 (HEMA + ECA) captured 72.2%. Four allergens, including HEMA, ECA, HEA, and diethylene glycol diacrylate 0.1% (DEGDA), captured >90%, and a 7-allergen series captured 100%, with no higher yield from additional acrylates in standard screening. Conclusions: Acrylate allergy is heterogeneous, comprising 2 subgroups, with cyanoacrylates co-reacting separately. Algorithm-guided series refinement improves diagnostic efficiency by prioritizing high-yield allergens for screening while minimizing unnecessary testing.
Vitamin D deficiency and systemic inflammation in hidradenitis suppurativa: clinical correlates in a retrospective cohort
Shrestha, Raslina , Van, Duc L., Tran, Hue T T, Ma, Jun, Alavi, Afsaneh, Davis, Mark, Wetter, David A, Lu, Kurt Q. , Nguyen, Giang H, Nguyen, Giang Huong , Tran, Hue T, Nguyen, Giang H , Tran, Hue T.T. , Alavi, Afsáneh , Davis, Mark D.P. , Wetter, David A.

British Journal of Dermatology | April 30, 2026 | Volume: 195 | Issue: 2 | Pages: 339-341

10.1093/bjd/ljag157 Get It

Vitamin D deficiency is frequently reported in hidradenitis suppurativa (HS), but its clinical significance remains unclear. In a retrospective cohort of 503 patients, deficiency was common and associated with demographic and metabolic factors but not with treatment-defined severity. Vitamin D deficiency was independently associated with elevated C-reactive protein, suggesting a link with systemic inflammation.
RATE OF PATCH TESTS REACTION TO A DERMATOPHAGOIDES MIX CURRENTLY ON THE MARKET: 29
Davis, Mark D. P. , Ahmed, Debra F, Davis, Mark D.P. , Ahmed, Debra D. F.

American Journal of Contact Dermatitis | April 17, 2026 | Volume: 12 | Issue: 2 | Pages: 129-129

10.1053/ajcd.2001.3151 Get It

DELAYED READINGS OF PATCH TEST REACTIONS TO TOPICAL CORTICOSTEROIDS: LOW YIELD
Davis, Mark Denis P., Richardson, Donna M., Farmer, Sara A., Davis, Mark D.P.

Dermatitis® | March 2, 2026 | Volume: 16 | Issue: 2 | Pages: 102-102

10.2310/derm.1.2005.2088 Get It

CONTACT SENSITIVITIES IN ORAL DISEASE
Torgerson, Rochelle R. , Davis, Mark Denis P., Bruce, Alison J., Farmer, Sara A., Rogers, Roy S., Davis, Mark D.P. , Rogers, Roy S.

Dermatitis® | March 2, 2026 | Volume: 16 | Issue: 2 | Pages: 100-100

10.2310/derm.1.2005.2083 Get It

PATCH TESTING TO THE DUST MITE ( DERMATOPHAGOIDES MIX, 0.1% PREPARATION): HIGH RATE OF REACTION IN BOTH ATOPIC AND NONATOPIC PATIENTS
Davis, Mark D. P. , Cheng, Janet F., Yiannias, James A. , Davis, Mark D.P.

Dermatitis® | March 2, 2026 | Volume: 16 | Issue: 2 | Pages: 99-100

10.2310/derm.1.2005.2082 Get It

BACK TO BASICS: IN CALCULATING PATCH TEST REACTIONS, SHOULD MACULAR ERYTHEMA AND LESSER REACTIONS BE INCLUDED?
Davis, Mark D.P., Yiannias, James A. , Davis, Mark D.P.

Dermatitis® | March 2, 2026 | Volume: 16 | Issue: 2 | Pages: 98-98

10.2310/derm.1.2005.2078 Get It

Low Yield for Extended Reading of Patch Tests with Topical Corticosteroids
Davis, Mark D. P., Richardson, Donna M., Farmer, Sara A., Davis, Mark D.P.

Dermatitis® | March 2, 2026 | Volume: 16 | Issue: 3 | Pages: 124-126

10.2310/derm.1.2005.2103 Get It

Patch-Test Reactions to Thioureas Are Frequently Relevant
Comfere, Nneka I. , Davis, Mark D. P., Fett, Debra D., Davis, Mark D.P.

Dermatitis® | March 2, 2026 | Volume: 16 | Issue: 3 | Pages: 121-123

10.2310/derm.1.2005.2102 Get It